Bismuth‐based compounds have recently gained increasing attention as potentially nontoxic and defect‐tolerant solar absorbers. However, many of the new materials recently investigated show limited photovoltaic performance. Herein, one such compound is explored in detail through theory and experiment: bismuth oxyiodide (BiOI). BiOI thin films are grown by chemical vapor transport and found to maintain the same tetragonal phase in ambient air for at least 197 d. The computations suggest BiOI to be tolerant to antisite and vacancy defects. All‐inorganic solar cells (ITO|NiOx|BiOI|ZnO|Al) with negligible hysteresis and up to 80% external quantum efficiency under select monochromatic excitation are demonstrated. The short‐circuit current densities and power conversion efficiencies under AM 1.5G illumination are nearly double those of previously reported BiOI solar cells, as well as other bismuth halide and chalcohalide photovoltaics recently explored by many groups. Through a detailed loss analysis using optical characterization, photoemission spectroscopy, and device modeling, direction for future improvements in efficiency is provided. This work demonstrates that BiOI, previously considered to be a poor photocatalyst, is promising for photovoltaics.
sources at 1000 lux had an irradiance of 340 and 320 µW cm −2 , respectively. The accuracy of the light meter and power meter is the primary determinant of the uncertainty in the measured PCE values, which amounts to approximately ±6-7%, as can be determined from a straightforward uncertainty analysis based on the device testing conditions and the specifications of the power and light meters. Consequently, the PCE values are reported herein with 1 decimal place.
Perovskite
nanoplatelets (NPls) hold promise for light-emitting
applications, having achieved photoluminescence quantum efficiencies
approaching unity in the blue wavelength range, where other metal-halide
perovskites have typically been ineffective. However, the external
quantum efficiencies (EQEs) of blue-emitting NPl light-emitting diodes
(LEDs) have reached only 0.12%. In this work, we show that NPl LEDs
are primarily limited by a poor electronic interface between the emitter
and hole injector. We show that the NPls have remarkably deep ionization
potentials (≥6.5 eV), leading to large barriers for hole injection,
as well as substantial nonradiative decay at the NPl/hole-injector
interface. We find that an effective way to reduce these nonradiative
losses is by using poly(triarylamine) interlayers, which lead to an
increase in the EQE of the blue (464 nm emission wavelength) and
sky-blue (489 nm emission wavelength) LEDs to 0.3% and 0.55%, respectively.
Our work also identifies the key challenges for further efficiency
increases.
Bismuth-based compounds have recently gained interest as solar absorbers with the potential to have low toxicity, be efficient in devices, and be processable using facile methods. We review recent theoretical and experimental investigations into bismuth-based compounds, which shape our understanding of their photovoltaic potential, with particular focus on their defect-tolerance. We also review the processing methods that have been used to control the structural and optoelectronic properties of single crystals and thin films. Additionally, we discuss the key factors limiting their device performance, as well as the future steps needed to ultimately realize these new materials for commercial applications.
Bismuth oxyiodide has anisotropic transport properties, and optimal device performance requires control over its preferred orientation. We find that this preferred orientation can be finely tuned through the precursor and substrate temperatures.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.